EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update. EZZ Life Science Holdings Ltd. has announced the issuance of 1,735,000 ordinary fully paid securities on October 30, 2024.

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update. EZZ Life Science Holdings Ltd. has announced a dividend of AUD 0.02 per fully ...

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update. EZZ Life Science Holdings Ltd. is set to hold its Annual General Meeting on ...

EZZ Life Science Holdings (ASX:EZZ) has had a great run on the share market with its stock up by a significant 92% over... Key Insights Using the Dividend Discount Model, EZZ Life Science Holdings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Australian market has recently seen a downturn, with the ASX200 closing at a seven-week low, driven by declines in sectors such as Health Care and Financials. Despite this challenging backdrop, ...

Lynk & Co has signed a cooperation agreement with Ezz Elarab Group in Egypt to officially promote its brand and products to ...

EZZ Life Science, Race Oncology and Orthocell are among ASX health companies reporting strong quarterly results this week.

EZZ Life Science Holdings will partner with the Australian Open, boosting its presence in key China and Southeast Asia markets. Genomic life science company EZZ Life Science Holdings Limited (ASX ...

Explore how EZZ's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Global ...

EZZ Life Science Holdings ( ASX:EZZ ) Full Year 2024 Results Key Financial Results Revenue: AU$66.4m (up 79% from FY... Key Insights EZZ Life Science Holdings' significant public companies ownership ...